Enzalutamide 160 mg

ENZULAMIDE 160 is a prescription medication containing Enzalutamide 160 mg, a potent androgen receptor inhibitor used in the treatment of metastatic and non-metastatic castration-resistant prostate cancer (CRPC). Enzalutamide works by blocking the action of androgens (male hormones) on prostate cancer cells, preventing their growth and spread.

Prostate cancer is one of the most common cancers among men, and advanced stages may become resistant to standard hormonal therapy. ENZULAMIDE 160 provides a targeted approach by directly inhibiting androgen receptor signaling, slowing disease progression, and improving survival rates in patients with advanced prostate cancer. Its once-daily oral administration makes it a convenient and effective option for long-term management under specialist supervision.

Uses

ENZULAMIDE 160 is primarily prescribed for:

• Metastatic castration-resistant prostate cancer (mCRPC)

• Non-metastatic castration-resistant prostate cancer in men with rising prostate-specific antigen (PSA) levels

• As part of hormonal therapy in patients who have received prior androgen deprivation therapy (ADT)

• Slowing disease progression and improving quality of life in advanced prostate cancer

It is not intended for use in women or children.

Benefits

ENZULAMIDE 160 offers several clinical benefits in the management of prostate cancer:

• Inhibits Cancer Cell Growth: Blocks androgen receptor activity, reducing proliferation of cancer cells

• Slows Disease Progression: Helps control tumor spread in advanced prostate cancer

• Convenient Oral Therapy: Once-daily capsules support patient adherence

• Improves Survival Outcomes: Clinical studies demonstrate prolonged overall survival in CRPC patients

• Reduces Complications: Helps minimize skeletal-related events and disease-related symptoms

• Supports Quality of Life: Controls symptoms such as pain, fatigue, and urinary issues associated with prostate cancer

Regular monitoring and consistent use enhance treatment effectiveness.

Dosage

The dosage of ENZULAMIDE 160 should be strictly determined by a qualified oncologist or healthcare provider:

• Recommended Dose: One 160 mg capsule once daily

• Administration: Can be taken with or without food; swallow whole with water

• Duration: Continued daily administration until disease progression or intolerable side effects occur

• Dose Adjustments: May be necessary in patients with liver impairment

Patients must not alter the dose or discontinue therapy without consulting their doctor, as it may affect treatment outcomes.

Side Effects

ENZULAMIDE 160 is generally well tolerated, but some patients may experience side effects. Common side effects include:

• Fatigue or weakness

• Hot flashes

• Headache or dizziness

• High blood pressure (hypertension)

• Gastrointestinal disturbances (nausea, diarrhea)

Less common but serious side effects:

• Seizures (rare)

• Heart rhythm changes (arrhythmias)

• Severe allergic reactions

• Liver enzyme abnormalities

Patients should report any unusual or severe symptoms immediately to their healthcare provider.

Precautions and Warning

• Pregnancy: ENZULAMIDE 160 is contraindicated in women who are or may become pregnant

• Liver or Kidney Disease: Use with caution in patients with hepatic or renal impairment

• Seizure History: Patients with a history of seizures should use under strict supervision

• Drug Interactions: Inform the doctor about all medications being taken, as Enzalutamide may interact with certain drugs

• Driving & Machinery: May cause dizziness or fatigue; exercise caution

• Regular Monitoring: PSA levels, liver function, and blood pressure should be periodically checked

Adherence to medical guidance ensures safety and effectiveness.

Conclusion

ENZULAMIDE 160 (Enzalutamide 160 mg) is a breakthrough oral therapy for advanced prostate cancer, offering targeted androgen receptor inhibition, slowing disease progression, and improving patient survival and quality of life. Its convenient once-daily capsule form makes it suitable for long-term therapy under medical supervision.

When taken as prescribed, ENZULAMIDE 160 provides a reliable and effective treatment option for men with metastatic or non-metastatic castration-resistant prostate cancer, helping manage symptoms, enhance overall well-being, and support long-term disease control.